Polymorphism of the β3-adrenergic receptor gene in morbid obesity

International Journal of Obesity

Volumn 20, Issue 12, 1996, Pages 1055-1061

  Oksanen, L ^a   Mustajoki, P ^b   Kaprio, J ^a   Kainulainen, K ^a   Janne O ^c   Peltonen, L ^d   Kontula, K ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b PEIJAS HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

3 adrenergic receptor gene; NIDDM; Obesity; Polymorphism; VLCD

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR;

ADULT; ALLELE; ARTICLE; BODY MASS; CALORIC RESTRICTION; CONTROLLED STUDY; EXERCISE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PATIENT COUNSELING; PRIORITY JOURNAL; WEIGHT GAIN;

ADULT; AGE OF ONSET; AGED; ALLELES; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DNA; FEEDING BEHAVIOR; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY, MORBID; PATIENT DROPOUTS; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3; WEIGHT LOSS;

EID: 0029841052     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Stunkard AJ. Genetic Contributions to Human Obesity, Genes, Brain and Behaviour. Raven Press, Ltd., New York 1991; pp. 205-218.
2. Bouchard C, Pérusse L. Genetics of Obesity. Annu Rev Nutr 1993; 13: 337-354.
3. Stunkard AJ. Current Views on Obesity. Am J Med 1996; 100: 230-236.
4. Friedman JM et al. Genetic Analysis of Complex Disorders. Molecular Mapping of Obesity Genes in Mice and Humans. Ann NY Acad Sci 1991; 630: 100-115.
5. Zhang Y et al. Positional Cloning of the Mouse Obese Gene and its Human Homologue. Nature 1994; 372: 425-432.
6. Chen H et al. Evidence that the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice. Cell 1996; 84: 491-495.
7. Naggert JK et al. Hyperproinsulinaemia in Obese Fat/Fat Mice Associated with a Carboxypeptidase E Mutation Which Reduces Enzyme Activity. Nature Genet 1995; 10: 135-142.
8. Bultman SJ, Michaud EJ, Woychick RP. Molecular Characterization of the Mouse Agouti Locus. Cell 1992; 71: 1195-1204.
9. Kwon HY et al. Molecular Structure and Chromosomal Mapping of the Human Homolog of the Agouti Gene. Proc Natl Acad Sci USA 1994; 91: 9760-9764.
10. Clément K, et al. Indication for Linkage of the Human Ob Gene Region with Extreme Obesity. Diabetes 1996; 45: 687-690.
11. Reed DR et al. Extreme Obesity may be linked to Markers Flanking the Human Ob Gene. Diabetes 1996; 45: 691-694.
12. Leibel RL, Bahary N, Friedman JM. Strategies for the Molecular Genetic Analysis of Obesity in Humans. Crit Rev Food Sci Nutr 1993; 33: 351-358.
13. 3-adrenergic Receptor and an Increased Capacity to Gain Weight in Patients with Morbid Obesity. N Engl J Med 1995; 333: 352-354.
14. 3-adrenergic-receptor gene. N Engl J Med 1995; 333: 343-347.
15. 3-adrenergic-receptor Gene With Features of the Insulin Resistance Syndrome in Finns. N Engl J Med 1995; 333: 348-351.
16. Henderson M, Freeman CPL. A Self-rating Scale for Bulimia. The 'BITE'. Brit J Psychiatr 1987; 150: 18-24.
17. Gormally J, Black S, Daston S, Rardin D. The Assessment of Binge Eating Severity among Obese Persons. Addict Behav 1982; 7: 47-55.
18. Stunkard AJ, Messick S. The Three-factor Eating Questionnaire to Measure Dietary Restraint, Disinhibition and Hunger. J Psychosom Res 1985; 29: 71-83.
19. Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: A Step in the Validation of a New Self-report Scale. Br J Psychiatr 1976; 128: 280-289.
20. Syvänen AC et al. A Primer-guided Nucleotide Incorporation Assay in the Genotyping of Apolipoprotein E. Genomics 1990; 8: 684-692.
21. Syvänen AC, Sajantila A, Lukka M. Identification of Individuals by Analysis of Biallelic DNA Markers, using PCR and Solid-phase Minisequencing. Am J Hum Genet 1993; 52: 46-59.
22. Banauch D et al. Eine Glucose-Dehydrogenase für die Glucose-bestimmung in Körperflüssigekeiten. Z Klin Chem Klin Biochem 1975; 13: 101-107.
23. Desbuquois B, Aurbach GD. Use of Polyethylene Glycol to Separate Free and Antibody-bound Peptide Hormones in Radioimmunoassays. J Clin Endocr 1971; 33: 732-738.
24. Bergmeyer. Metoden der Enzymatischen Analyse, 3. Auflage, Bd. II, Verlag Chemie Weinheim 1974; p 1878.
25. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the Enzymatic Determination of Serum Total Cholesterol with Improved Lipolytic Efficiency. Clin Chem 1983; 29: 1075-1080.
26. 2+/Dextran Sulphate in its Enzymic Measurement. Clin Chem 1978; 24: 931-933.
27. 3-adrenergic Receptor. Mol Pharmacol 1991; 40: 895-899.
28. 3-adrenergic receptor mRNA in Man. J Clin Invest 1993; 91: 344-349.
29. 1-adrenergic Receptors in Adipose Tissue of Congenitally Obese (C57BL/6J ob/ob) Mice. Mol Endocrinol 1994; 8: 518-527.
30. Muzzin P et al. An Adipose Tissue-specific β-adrenergic Receptor: Molecular Cloning and Down-regulation in Obesity. J Biol Chem 1991; 266: 24053-24058.
31. 3-adrenoreceptors in Obesity. J Clin Invest 1995; 95: 1109-1116.
32. 3-adrenergic receptor gene. J Biol Chem 1995; 270: 29483-29492.
33. Hamann A, Flier JS, Lowell BB. Decreased Brown Fat Markedly Enhances Susceptibility to Diet-induced Obesity, Diabetes, and Hyperlipidemia. Endocrinology 1996; 137: 21-29.
34. 3-adrenergic Receptor Gene in Normal Weight and Obese Subjects. Diabetologia 1996; 39: 857-860.
35. Caro JF. Clinical Review 26: Insulin Resistance in Obese and Nonobese Man. J Clin Endocrinol Metab 1991; 73: 691-695.
36. 3-adrenergic Receptor mRNA in the Human Brain. Brain Res 1994; 29: 369-375.
37. 3-adrenergic Receptor Gene and Response to Treatment of Obesity. Lancet 1995; 346: 1433-1434.